Oxidative Stress Contributes to the Tamoxifen-Induced Killing of Breast Cancer Cells: Implications for Tamoxifen Therapy and Resistance

Scientific Reports - United Kingdom
doi 10.1038/srep21164
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sphingosine Kinase 1 Activation by Estrogen Receptor Α36 Contributes to Tamoxifen Resistance in Breast Cancer

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2018English

Selective Recruitment of Breast Cancer Anti-Estrogen Resistance Genes and Relevance for Breast Cancer Progression and Tamoxifen Therapy Response

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2010English

Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2018English

A Molecular Model for the Mechanism of Acquired Tamoxifen Resistance in Breast Cancer

European Journal of Cancer
Cancer ResearchOncology
2014English

LAMP3 Is Involved in Tamoxifen Resistance in Breast Cancer Cells Through the Modulation of Autophagy

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

Immature O-Glycans Recognized by the Macrophage Glycoreceptor CLEC10A (MGL) Are Induced by 4-Hydroxy-Tamoxifen, Oxidative Stress and DNA-damage in Breast Cancer Cells

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2019English

AKT1 - A New Marker for Tamoxifen Resistance in ER-Dependent Breast Cancer

2004English

Pap Smear Results of Women With Breast Cancer Using Tamoxifen Therapy

Istanbul Medical Journal
2016English

Role of Dynein Light Chain 1 in Tamoxifen Resistance in Breast Cancer

2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy